Clinical trials
Major Depressive Disorder trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 8 |
| Unknown status | 8 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lundbeck A/S | 7 |
| Janssen Research & Development, LLC | 7 |
| Eli Lilly and Company | 5 |
| IRCCS Centro San Giovanni di Dio Fatebenefratelli | 3 |
| AstraZeneca | 2 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2 |
| GlaxoSmithKline | 2 |
| IRCCS San Raffaele | 2 |
| Neurocrine Biosciences | 2 |
| Alessio Fasano | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 49 |
| Depressive Disorder, Treatment-Resistant | 3 |
| Inflammation | 2 |
| Mood Disorders | 2 |
| Anhedonia | 1 |
| Anorexia Nervosa | 1 |
| Anxiety Disorders | 1 |
| Bipolar Disorder | 1 |
| Dementia | 1 |
| Depressive Disorder | 1 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.